Contributed by: Dennis Fortier, President, Medical Care Corporation
________________________________________________
The National Alzheimer's Association plays a central role in promoting awareness of, directing research dollars for, lobbying for effective policy against, and providing a framework through which we can all grasp the seriousness of Alzheimer's disease. A current theme that they are promoting is the urgent need for more federal funds for research.
The argument supporting such an investment is cogently summarized in a recent editorial written by Harry Johns, CEO of the National Alzheimer's Association. The statistics are sobering and the call for increased research support is clear.
The Alzheimer's Breakthrough Act, currently before Congress, would authorize $2B in research funding and escalate the urgency we need to effectively combat this disease. For all of you who are politically active, I urge you to voice your support for this initiative. For those of you who are not, I would suggest this might be a good time to become so.
Posts
AI’s role in simplifying communication [PODCAST]
9 hours ago
It is important for patients and families affected by diseases such as Alzheimer’s to consider participating in clinical studies. One such study is the ICARA Study (www.icarastudy.com), whose goal is to explore if an investigational drug, called Bapineuzumab, can help slow the progression of Alzheimer’s Disease. Clinical studies that test new treatments are the best chance we have for fighting this disease. Current therapies for Alzheimer’s treat the symptoms associated with it, not the disease itself.
ReplyDelete